Stock listing
NASDAQ:TELO Telomir Pharmaceuticals, Inc. Stock
Home listing (NASDAQ) of Telomir Pharmaceuticals, Inc.
Follow Telomir Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:TELO
$1.05 USD 0.00 (0.0%)
Close on Oct 16, 2026
- Ticker
- NASDAQ:TELO
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 6, 2026
Telomir Pharmaceuticals Secures $5.6 Million Financing as Billionaire Entrepreneur John Paul DeJoria Increases Investment in the Company
Latest deck · July 2026
Investor Presentation (July 2026)
Investor deck · 25 slides
Latest news
Financings
Private placement of common stock
Oct 6, 2026
Announced: about US$5.6M · US$1.16 a share · Alexander Capital, L.P.
Dealers: Alexander Capital, L.P. (lead)
Buyers: John Paul DeJoria (additional $1.0 million investment)
Use of proceeds: Clinical development of Telomir-Zn, including its Phase 1/2 program in advanced or metastatic TNBC, plus working capital and general corporate purposes
Decks
Investor Presentation (July 2026)
Investor deck · 25 slides · July 2026
Corporate Update (April 2024)
Corporate update · 31 slides · Apr 15, 2024
Telomir Pharmaceuticals, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 20 in the last 12 months · 59 in all · newest Oct 6, 2026 · oldest 2024
- Decks
- 2 decks · latest July 2026
Where Telomir Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:TELO · Home listing · This page | NASDAQ | United States | USD |
| BOATS:TELO | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Telomir Pharmaceuticals, Inc.